Diabetes and endometrial cancer: An Italian case-control

Fabio Parazzini, Carlo La Vecchia, Eva Negri, Gian Luca Riboldi, Matteo Surace, Guido Benzi, Aldo Maina, Francesca Chiaffarino

Research output: Contribution to journalArticle

Abstract

We considered the association between diabetes and risk of endometrial cancer using data from a large case-control study conducted in Italy. Cases were 752 women with incident, histologically confirmed endometrial cancer <75 years of age (median age 60 years, range 28-74) admitted to a network of hospitals in Milan. Controls were 2,606 patients (median age 54 years, range 25-74) aged <75 years, admitted for acute non-neoplastic, non-gynecological, non-hormone-related conditions to the same network of hospitals where cases had been identified. A total of 132 (17.6%) cases and 116 controls (4.5%) reported a history of diabetes. The corresponding multivariate odds ratio (OR) was 2.9 [95% confidence interval (CI) 2.2-3.9]. No association emerged with diabetes diagnosed under age 40 (likely to be insulin-dependent diabetes), whereas the OR of endometrial cancer was 3.1 (95% CI 2.3-4.2) for diabetes diagnosed at age ≥40 years. The OR of endometrial cancer in women with history of diabetes was 3.0 for women with a body mass index (BMI) (QI) kg/m2 <25, 3.6 for those with a BMI of 25-29, and 3.3 for those with a BMI ≥30. No consistent interaction or modifying effect was observed for any other covariate. Our results confirm that non-insulin-dependent diabetes is associated with the risk of endometrial cancer. The association may be mediated through elevated oestrogen levels in diabetic women, hyperinsulinemia or insulin-like growth factor-1 (IGF-1).

Original languageEnglish
Pages (from-to)539-542
Number of pages4
JournalInternational Journal of Cancer
Volume81
Issue number4
DOIs
Publication statusPublished - 1999

Fingerprint

Endometrial Neoplasms
Body Mass Index
Odds Ratio
Confidence Intervals
Hyperinsulinism
Somatomedins
Italy
Case-Control Studies
Estrogens
Insulin

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Diabetes and endometrial cancer : An Italian case-control. / Parazzini, Fabio; La Vecchia, Carlo; Negri, Eva; Riboldi, Gian Luca; Surace, Matteo; Benzi, Guido; Maina, Aldo; Chiaffarino, Francesca.

In: International Journal of Cancer, Vol. 81, No. 4, 1999, p. 539-542.

Research output: Contribution to journalArticle

Parazzini, Fabio ; La Vecchia, Carlo ; Negri, Eva ; Riboldi, Gian Luca ; Surace, Matteo ; Benzi, Guido ; Maina, Aldo ; Chiaffarino, Francesca. / Diabetes and endometrial cancer : An Italian case-control. In: International Journal of Cancer. 1999 ; Vol. 81, No. 4. pp. 539-542.
@article{423dd72161c548ea9d012a532fb373ac,
title = "Diabetes and endometrial cancer: An Italian case-control",
abstract = "We considered the association between diabetes and risk of endometrial cancer using data from a large case-control study conducted in Italy. Cases were 752 women with incident, histologically confirmed endometrial cancer <75 years of age (median age 60 years, range 28-74) admitted to a network of hospitals in Milan. Controls were 2,606 patients (median age 54 years, range 25-74) aged <75 years, admitted for acute non-neoplastic, non-gynecological, non-hormone-related conditions to the same network of hospitals where cases had been identified. A total of 132 (17.6{\%}) cases and 116 controls (4.5{\%}) reported a history of diabetes. The corresponding multivariate odds ratio (OR) was 2.9 [95{\%} confidence interval (CI) 2.2-3.9]. No association emerged with diabetes diagnosed under age 40 (likely to be insulin-dependent diabetes), whereas the OR of endometrial cancer was 3.1 (95{\%} CI 2.3-4.2) for diabetes diagnosed at age ≥40 years. The OR of endometrial cancer in women with history of diabetes was 3.0 for women with a body mass index (BMI) (QI) kg/m2 <25, 3.6 for those with a BMI of 25-29, and 3.3 for those with a BMI ≥30. No consistent interaction or modifying effect was observed for any other covariate. Our results confirm that non-insulin-dependent diabetes is associated with the risk of endometrial cancer. The association may be mediated through elevated oestrogen levels in diabetic women, hyperinsulinemia or insulin-like growth factor-1 (IGF-1).",
author = "Fabio Parazzini and {La Vecchia}, Carlo and Eva Negri and Riboldi, {Gian Luca} and Matteo Surace and Guido Benzi and Aldo Maina and Francesca Chiaffarino",
year = "1999",
doi = "10.1002/(SICI)1097-0215(19990517)81:4<539::AID-IJC6>3.0.CO;2-Q",
language = "English",
volume = "81",
pages = "539--542",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Diabetes and endometrial cancer

T2 - An Italian case-control

AU - Parazzini, Fabio

AU - La Vecchia, Carlo

AU - Negri, Eva

AU - Riboldi, Gian Luca

AU - Surace, Matteo

AU - Benzi, Guido

AU - Maina, Aldo

AU - Chiaffarino, Francesca

PY - 1999

Y1 - 1999

N2 - We considered the association between diabetes and risk of endometrial cancer using data from a large case-control study conducted in Italy. Cases were 752 women with incident, histologically confirmed endometrial cancer <75 years of age (median age 60 years, range 28-74) admitted to a network of hospitals in Milan. Controls were 2,606 patients (median age 54 years, range 25-74) aged <75 years, admitted for acute non-neoplastic, non-gynecological, non-hormone-related conditions to the same network of hospitals where cases had been identified. A total of 132 (17.6%) cases and 116 controls (4.5%) reported a history of diabetes. The corresponding multivariate odds ratio (OR) was 2.9 [95% confidence interval (CI) 2.2-3.9]. No association emerged with diabetes diagnosed under age 40 (likely to be insulin-dependent diabetes), whereas the OR of endometrial cancer was 3.1 (95% CI 2.3-4.2) for diabetes diagnosed at age ≥40 years. The OR of endometrial cancer in women with history of diabetes was 3.0 for women with a body mass index (BMI) (QI) kg/m2 <25, 3.6 for those with a BMI of 25-29, and 3.3 for those with a BMI ≥30. No consistent interaction or modifying effect was observed for any other covariate. Our results confirm that non-insulin-dependent diabetes is associated with the risk of endometrial cancer. The association may be mediated through elevated oestrogen levels in diabetic women, hyperinsulinemia or insulin-like growth factor-1 (IGF-1).

AB - We considered the association between diabetes and risk of endometrial cancer using data from a large case-control study conducted in Italy. Cases were 752 women with incident, histologically confirmed endometrial cancer <75 years of age (median age 60 years, range 28-74) admitted to a network of hospitals in Milan. Controls were 2,606 patients (median age 54 years, range 25-74) aged <75 years, admitted for acute non-neoplastic, non-gynecological, non-hormone-related conditions to the same network of hospitals where cases had been identified. A total of 132 (17.6%) cases and 116 controls (4.5%) reported a history of diabetes. The corresponding multivariate odds ratio (OR) was 2.9 [95% confidence interval (CI) 2.2-3.9]. No association emerged with diabetes diagnosed under age 40 (likely to be insulin-dependent diabetes), whereas the OR of endometrial cancer was 3.1 (95% CI 2.3-4.2) for diabetes diagnosed at age ≥40 years. The OR of endometrial cancer in women with history of diabetes was 3.0 for women with a body mass index (BMI) (QI) kg/m2 <25, 3.6 for those with a BMI of 25-29, and 3.3 for those with a BMI ≥30. No consistent interaction or modifying effect was observed for any other covariate. Our results confirm that non-insulin-dependent diabetes is associated with the risk of endometrial cancer. The association may be mediated through elevated oestrogen levels in diabetic women, hyperinsulinemia or insulin-like growth factor-1 (IGF-1).

UR - http://www.scopus.com/inward/record.url?scp=0032963713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032963713&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0215(19990517)81:4<539::AID-IJC6>3.0.CO;2-Q

DO - 10.1002/(SICI)1097-0215(19990517)81:4<539::AID-IJC6>3.0.CO;2-Q

M3 - Article

C2 - 10225441

AN - SCOPUS:0032963713

VL - 81

SP - 539

EP - 542

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 4

ER -